Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-26

FDA Approved: FYCOMPA — Supplemental Application (Eisai Inc.)

View source ↗

Summary

FDA approved a supplemental application for FYCOMPA (perampanel) submitted by Eisai Inc. The action expands the product's labeling to reflect new or expanded in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fycompa (perampanel)

Snippet

SUPPL AP for FYCOMPA (PERAMPANEL)